Serum amyloid A facilitates expansion of CD4+ T cell and CD19+ B cell subsets implicated in the severity of myasthenia gravis patients

Documenti analoghi

• Dynamic changes of peripheral inflammatory markers link with disease severity and predict short‐term poor outcome of myasthenia gravis
  di: Yiyun Weng, et al.
  Pubblicazione: (2024)
• Convergent effects of synthetic glucocorticoid dexamethasone and amyloid beta in human olfactory neurosphere‐derived cells
  di: Zane Farnum, et al.
  Pubblicazione: (2024)
• Photobiomodulation in the infrared spectrum reverses the expansion of circulating natural killer cells and brain microglial activation in Sanfilippo mice
  di: A. A. Lau, et al.
  Pubblicazione: (2024)
• Higher CSF sTREM2 attenuates APOE ε4 ‐related risk for amyloid pathology in cognitively intact adults: The CABLE study
  di: Yong‐Chang Wang, et al.
  Pubblicazione: (2024)
• Correction to “Constitutive alpha‐secretase cleavage of the beta‐amyloid precursor protein in the furin‐deficient LoVo cell line: involvement of the pro‐hormone convertase 7 and the disintegrin and metalloprotease ADAM10”
  Pubblicazione: (2024)